Five thousand leaders, one in three of them holding an executive title, descended on the RAI Amsterdam from 15th to 18th June 2026 for HLTH Europe. The call to action this year was "Step Outside", a deliberate nudge to leave the comfort zone, look at familiar problems from unfamiliar angles, and find energy in collaboration across boundaries. For those of us who spend our days on the deal side of digital health, the phrase turned out to be an unusually accurate description of

The Exit Factor: Why M&A is on the rise in HealthTech. By mid-2025 healthcare deal value had soared 87% to €31.8 billion, even as deal count slid 8% according to Nelson Advisors. In the UK, 168 healthtech exits landed by the end of 2024 against just 61 failures. M&A is no longer a side strategy; it’s the headline act and primary way buyers access innovation, capability, and competitive edge.